Archive for October, 2009

Blood calcium levels may be linked to prostate cancer death

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Research finds that men with high blood calcium levels are more likely to develop fatal prostate cancer than men with lower blood calcium levels.

Radical prostatectomy vs. watchful waiting

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Results

Rapaflo approved for the treatment of BPH

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men

No “home run” for proton radiation–at least not yet

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

A clinical trial of proton radiation for early prostate cancer found that the treatment is safe and well-tolerated by patients, but probably no better than other, less expensive forms of radiation.

Radiation therapy may up colon cancer risk

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men

What is the difference between PSA and free PSA?

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Kevin R. Loughlin, M.D., M.B.A., director of Urologic Research at Brigham and Women’s Hospital, explains how these tests differ.